knowledge -WSS

knowledge

author：Wikipedia 2025-09-30 00:36:00 - browse：4

Kidney transplants are the most common organ transplant procedure in the U.S., with 25,000 taking place in 2022. But for patients who receive new kidneys, the transplant is often followed by severe lifelong challenges, many of which are linked to the immunosuppression drug regimen required after surgery to ensure the body does not reject the new organ. These treatments have side effects and toxicities that impact patients’ long-term health, and even survival, leading to a transplant failure rate of 30-50% at the 10-year mark.

Now a new trial sponsored by Medeor Therapeutics, the results of which were presented Thursday at the American Society of Nephrology (ASN) Kidney Week 2023 Annual Meeting, offers hope that stem cell therapy may help patients discontinue their immunosuppressant regime within a year of the transplant.

“The ability to get a transplant without being on lifelong immunosuppression is kind of a dream in transplant, so I can see why this would generate a lot of excitement,” said Sommer Gentry, a professor of surgery at New York University, who was not involved in the study and was not at the actual presentation, but reviewed the trial’s presentation slides.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Intellia plays down concerns on accidental germline transmission

explore

WSS

Republicans love RFK Jr. What's that tell us about health in 2024?

Study: Spinal cord stimulation helps patients with paralysis walk again

Reframing the conversation around gain

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Reframing the conversation around gain

Wegovy improves function in certain heart failure patients

hotspot

knowledge

Wikipedia

As demand for Covid shots wanes, Moderna seeks its next success

How the drug

Hepatitis C has a cure — but many Americans still lack access to it

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

ChatGPT in medicine: STAT answers readers' burning questions

Can U.S. cancer drug shortages be fixed?

Activists slam private health insurers over coverage restrictions

How Brent Saunders' Allergan experiment failed

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Wegovy improves function in certain heart failure patients

Wikipedia

How the first Native Hawaiian psychiatrist helped diversify medicine

Trans patients at the end of life deserve respect and dignity

Florida babysitter arrested over hot car death, authorities say

PBMs are inflating the cost of generic drugs. They must be reined in

Trump Organization, Michael Cohen agree to settle million

Trump Organization, Michael Cohen agree to settle million

hotspot

hotspot

explore

knowledge